» Authors » Mohamed Ramdani

Mohamed Ramdani

Explore the profile of Mohamed Ramdani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 187
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Balayssac D, Kerckhove N, Selvy M, Pereira B, Gonneau C, Petorin C, et al.
Support Care Cancer . 2024 Jun; 32(7):427. PMID: 38869647
Purpose: Sensory chemotherapy-induced peripheral neuropathy (CIPN) is well-recognized, but motor CIPN remains understudied. This secondary analysis focused on the long-term severity and impact of motor disorders, their relation to sensory...
2.
Ouahabi S, Loukili E, Daoudi N, Chebaibi M, Ramdani M, Rahhou I, et al.
Mar Drugs . 2023 Jul; 21(7). PMID: 37504903
In this study, a comparison was made of the chemical makeup of different extracts obtained from , a type of red seaweed that was gathered from the Nador lagoon situated...
3.
Rudler F, Pineton de Chambrun G, Lallemant B, Garrel R, Pouderoux P, Ramdani M, et al.
Surg Endosc . 2023 Jun; 37(9):7064-7072. PMID: 37380740
Background And Study Aim: Zenker's diverticulum is a rare disease that affects quality of life due to dysphagia and regurgitation. This condition can be treated by various surgical or endoscopic...
4.
Ouahabi S, Loukili E, Elbouzidi A, Taibi M, Bouslamti M, Nafidi H, et al.
Life (Basel) . 2023 Jun; 13(6). PMID: 37374175
The mastic tree, scientifically known as , which belongs to the Anacardiaceae family, was used in this study. The aim of this research was to analyze the chemical composition of...
5.
Kerckhove N, Selvy M, Lambert C, Gonneau C, Feydel G, Petorin C, et al.
Front Pharmacol . 2021 Nov; 12:744085. PMID: 34803689
Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors. Based on a previous cross-sectional study assessing oxaliplatin-related sensory...
6.
Selvy M, Pereira B, Kerckhove N, Gonneau C, Feydel G, Petorin C, et al.
J Clin Med . 2020 Jul; 9(8). PMID: 32727095
(1) Background: Oxaliplatin is among the most neurotoxic anticancer drugs. Little data are available on the long-term prevalence and consequences of chemotherapy-induced peripheral neuropathy (CIPN), even though the third largest...
7.
Assenat E, Pageaux G, Thezenas S, Peron J, Becouarn Y, Seitz J, et al.
Br J Cancer . 2019 Apr; 120(9):896-902. PMID: 30944458
Background: Sorafenib remains one major first-line therapeutic options for advanced hepatocellular carcinoma (aHCC), with modest efficacy. We investigated the addition of gemcitabine and oxaliplatin (GEMOX) to sorafenib in aHCC patients....
8.
Aparicio T, Gargot D, Teillet L, Maillard E, Genet D, Cretin J, et al.
Eur J Cancer . 2016 Nov; 74:98-108. PMID: 27825697
Aim: Several predictors of metastatic colorectal cancer (mCRC) outcomes have been described. Specific geriatric characteristics could be of interest to determine prognosis. Method: Elderly patients (75+) with previously untreated mCRC...
9.
Khemissa F, Mineur L, Amsellem C, Assenat E, Ramdani M, Bachmann P, et al.
Dig Liver Dis . 2016 Jan; 48(3):327-32. PMID: 26776879
Background: Patients with gastrointestinal (GI) cancer are exposed to cachexia, which is highly correlated with chemotherapy-induced side effects. Research suggests that specific immunonutrients could prevent such toxicities. Aims: The primary...
10.
Jayed M, Benbrahim S, Bakkas S, Ramdani M, Flower R
Bull Environ Contam Toxicol . 2015 Apr; 94(5):614-21. PMID: 25829056
This study focused on the analysis of organochlorine pesticides and PCBs in tissue samples of the clam, Ruditapes decussatus, in the Oualidia lagoon. Tissue assays were conducted during February to...